Legal & General Group’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-142
| Closed | -$2.35K | – | 3523 |
|
2024
Q1 | $2.35K | Hold |
142
| – | – | ﹤0.01% | 3339 |
|
2023
Q4 | $2.27K | Buy |
142
+28
| +25% | +$447 | ﹤0.01% | 3363 |
|
2023
Q3 | $8.68K | Hold |
114
| – | – | ﹤0.01% | 3294 |
|
2023
Q2 | $7.48K | Buy |
+114
| New | +$7.48K | ﹤0.01% | 3348 |
|
2022
Q2 | – | Sell |
-70
| Closed | -$2K | – | 3684 |
|
2022
Q1 | $2K | Hold |
70
| – | – | ﹤0.01% | 3553 |
|
2021
Q4 | $6K | Buy |
70
+14
| +25% | +$1.2K | ﹤0.01% | 3538 |
|
2021
Q3 | $4K | Sell |
56
-15
| -21% | -$1.07K | ﹤0.01% | 3489 |
|
2021
Q2 | $7K | Buy |
+71
| New | +$7K | ﹤0.01% | 3448 |
|